Abeona Therapeutics Inc. (ABEO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
5.41
0.09 (1.69%)
At close: Oct 03, 2025, 3:59 PM
5.50
1.66%
After-hours: Oct 03, 2025, 06:30 PM EDT

Abeona Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
23.36M 14.47M 14.22M 32.94M
Short-Term Investments
74.36M 37.75M 37.93M 12.09M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
96K 277K 43K 168K
Receivables
1.65M 2.44M 188K 3M
Inventory
n/a n/a n/a n/a
Other Current Assets
1.48M 338K 424K 891K
Total Current Assets
100.85M 55.74M 53.1M 56.29M
Property-Plant & Equipment
7.98M 7.99M 11.07M 21.74M
Goodwill & Intangibles
n/a n/a n/a 1.38M
Total Long-Term Assets
8.08M 8.27M 11.12M 23.29M
Total Assets
108.93M 64M 64.21M 79.59M
Account Payables
3.44M 1.86M 1.81M 4.33M
Deferred Revenue
n/a n/a n/a 296K
Short-Term Debt
5.93M n/a n/a n/a
Other Current Liabilities
4.46M 3.69M 1.6M 1.79M
Total Current Liabilities
16.59M 13.42M 7.78M 16.62M
Long-Term Debt
13.04M n/a n/a n/a
Other Long-Term Liabilities
32.01M 31.35M 23.82M 13.04M
Total Long-Term Liabilities
48.31M 35.75M 29.67M 20.59M
Total Liabilities
64.9M 49.18M 37.45M 37.22M
Total Debt
23.05M 5.4M 7.63M 9.38M
Book Value
44.03M 14.83M 26.76M 42.37M
Book Value Per Share
1.07 0.69 3.40 10.76
Common Stock
457K 265K 177K 1.47M
Retained Earnings
-813.26M -749.52M -695.34M -655.64M
Comprehensive Income
8K -66K -129K -27K
Shareholders Equity
44.03M 14.83M 26.76M 42.37M
Total Investments
74.36M 37.75M 37.93M 12.09M